Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).
about
Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick GetawayMurine Cytomegalovirus Deubiquitinase Regulates Viral Chemokine Levels To Control Inflammation and PathogenesisBovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M.An essential role for the proximal but not the distal cytoplasmic tail of glycoprotein M in murid herpesvirus 4 infection.A derivative of platelet-derived growth factor receptor alpha binds to the trimer of human cytomegalovirus and inhibits entry into fibroblasts and endothelial cellsQuantitative temporal viromics: an approach to investigate host-pathogen interactionCharacterization of the varicella-zoster virus ORF50 gene, which encodes glycoprotein M.HCMV spread and cell tropism are determined by distinct virus populations.Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblastsB cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies.Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropismPrevention of maternal cytomegalovirus infection: current status and future prospects.Identification of glycoprotein gpTRL10 as a structural component of human cytomegalovirusRecent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.Progress toward an elusive goal: current status of cytomegalovirus vaccines.Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies.Glycoprotein M of herpes simplex virus 1 is incorporated into virions during budding at the inner nuclear membrane.Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.Human Cytomegalovirus gH/gL Forms a Stable Complex with the Fusion Protein gB in Virions.Synthetic DNA approach to cytomegalovirus vaccine/immune therapyVaricella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spreadVaccine strategies against human cytomegalovirus infection.Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.Human cytomegalovirus entry into cells.Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome.Human cytomegalovirus infection and atherothrombosis.Human CMV transcripts: an overview.Principles for studying in vivo attenuation of virus mutants: defining the role of the cytomegalovirus gH/gL/gO complex as a paradigm.Herpes simplex virus 1 gN partners with gM to modulate the viral fusion machinery.Recovery of an HMWP/hmwBP (pUL48/pUL47) complex from virions of human cytomegalovirus: subunit interactions, oligomer composition, and deubiquitylase activity.Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge.The gene 10 (UL49.5) product of equine herpesvirus 1 is necessary and sufficient for functional processing of glycoprotein M.Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells.The human cytomegalovirus UL35 gene encodes two proteins with different functions.HCMV-encoded glycoprotein M (UL100) interacts with Rab11 effector protein FIP4.Effects of simultaneous deletion of pUL11 and glycoprotein M on virion maturation of herpes simplex virus type 1Cytomegalovirus UL128 homolog mutants that form a pentameric complex produce virus with impaired epithelial and trophoblast cell tropism and altered pathogenicity in the guinea pig.Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response.The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV.
P2860
Q24531303-3AF53BA1-7030-4BEC-B952-58A7CCA79456Q26745798-CB1D33FA-9AF3-4A9B-828D-736DA5B1F62AQ28468563-6E8D8BB5-46FA-40E2-BEA2-E07886B6D7B6Q33244993-E2C0D8CD-B08C-42D2-9B2F-E34DE2EBE0FDQ33332118-034553D4-1FF6-476C-84D5-BCF09DEE2337Q33558900-483B295C-2C57-4268-B454-743C3D85D583Q33722378-1C8ED77E-BE19-46A7-A2DA-9FE064B5EF9EQ33725728-7FECA42F-989C-42D2-A15D-E7BDA3B1159DQ33798083-8E5F443D-8FC5-480F-9821-EEEC401E779BQ33987451-06652DA7-8756-44A3-B679-A8ADCCA9F57DQ33996614-DF2B647A-CD4B-45EA-9AD9-3830364E9BCCQ34212879-4467EECB-50EE-444B-A89C-9E79EB9CB6C2Q34272089-417B72E1-5B37-429E-9533-8D7E079D0C5EQ34328645-4FC0F9CB-92FD-4457-A1A0-94236D122087Q34349745-D3C81710-E744-4A86-9692-09A3D8A39E4EQ34434818-E3AF5667-1E8A-4CB9-9104-8EF5FDF0055CQ34468958-0FB723C4-090C-461D-87A8-E0FD541DCDBDQ35635003-33E41BA1-7736-4F25-96AD-2B51C403A902Q35751946-C43F4685-7A6C-4641-8D7A-78F547B9E790Q35991173-00C32E9E-DBFF-4892-A44E-6D6F74E30851Q36069582-ACFA8C78-5AFB-4D88-B86A-B366AFBA221AQ36424473-C73BA9E8-E3A1-469B-ABE1-B5714D2F1FC7Q36839736-2B82D401-6258-4DE7-9C59-410B68B84C11Q37406553-A9345128-C8E5-4196-92AA-D045A517736DQ37431029-939E057F-FBA6-43F8-B729-2173F4CC7DFBQ37568012-2B468755-3D98-4D90-B9FD-BE348D7F24DFQ37967568-E92AD802-32A2-476D-9625-BD524F2650E3Q38008469-61399E99-3A41-4DCD-8F11-32ED5260B270Q38381730-F30780D6-AA63-42EB-8A6C-1CE5B8A26BA1Q38928605-EF2010A3-1555-4D8B-9B87-252F0D2EE9B7Q38994872-3891E2EA-F766-4473-86B8-575A464FE361Q39411419-81FA7D24-F53B-4423-BBD5-E6C1A8763ABAQ39682828-58283BCA-C478-4777-B6E3-9978FB90487DQ39682836-01286A35-4A29-48C2-A5B1-A2DF2C24987DQ39748059-846DFAAE-E520-4163-9769-CCE50D22B42DQ39798434-72D9778F-28B2-4F01-AB1A-30EB14D43CD5Q39917711-FCA3700D-E2B2-45A2-AC0B-BCA44DFBED2CQ40145257-A9D516B7-3E26-425E-AC02-787EAC7FABEDQ40292980-62B170EF-781C-4914-BF73-F4D4E9FD17E4Q40340374-31B36337-C3E8-4503-8679-84CAC3061091
P2860
Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).
@ast
Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).
@en
type
label
Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).
@ast
Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).
@en
prefLabel
Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).
@ast
Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).
@en
P2093
P2860
P1433
P1476
Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).
@en
P2093
P2860
P304
11881-11892
P356
10.1128/JVI.74.24.11881-11892.2000
P577
2000-12-01T00:00:00Z